These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

744 related items for PubMed ID: 19558253

  • 1. Daptomycin therapy for vancomycin-resistant enterococcal bacteremia: a retrospective case series of 30 patients.
    Gallagher JC, Perez ME, Marino EA, LoCastro LG, Abrardo LA, MacDougall C.
    Pharmacotherapy; 2009 Jul; 29(7):792-9. PubMed ID: 19558253
    [Abstract] [Full Text] [Related]

  • 2. Vancomycin-resistant enterococcal bacteraemia and daptomycin: are higher doses necessary?
    King EA, McCoy D, Desai S, Nyirenda T, Bicking K.
    J Antimicrob Chemother; 2011 Sep; 66(9):2112-8. PubMed ID: 21697178
    [Abstract] [Full Text] [Related]

  • 3. High-dose daptomycin for treatment of complicated gram-positive infections: a large, multicenter, retrospective study.
    Kullar R, Davis SL, Levine DP, Zhao JJ, Crank CW, Segreti J, Sakoulas G, Cosgrove SE, Rybak MJ.
    Pharmacotherapy; 2011 Jun; 31(6):527-36. PubMed ID: 21923436
    [Abstract] [Full Text] [Related]

  • 4. Daptomycin for the treatment of gram-positive bacteremia and infective endocarditis: a retrospective case series of 31 patients.
    Segreti JA, Crank CW, Finney MS.
    Pharmacotherapy; 2006 Mar; 26(3):347-52. PubMed ID: 16503714
    [Abstract] [Full Text] [Related]

  • 5. Safety and clinical outcomes when utilizing high-dose (> or =8 mg/kg) daptomycin therapy.
    Moise PA, Hershberger E, Amodio-Groton MI, Lamp KC.
    Ann Pharmacother; 2009 Jul; 43(7):1211-9. PubMed ID: 19584384
    [Abstract] [Full Text] [Related]

  • 6. Vancomycin-resistant enterococcal bacteraemia: is daptomycin as effective as linezolid?
    Mave V, Garcia-Diaz J, Islam T, Hasbun R.
    J Antimicrob Chemother; 2009 Jul; 64(1):175-80. PubMed ID: 19423543
    [Abstract] [Full Text] [Related]

  • 7. Daptomycin therapy for invasive Gram-positive bacterial infections in children.
    Ardura MI, Mejías A, Katz KS, Revell P, McCracken GH, Sánchez PJ.
    Pediatr Infect Dis J; 2007 Dec; 26(12):1128-32. PubMed ID: 18043450
    [Abstract] [Full Text] [Related]

  • 8. Clinical outcomes of patients receiving daptomycin for the treatment of Staphylococcus aureus infections and assessment of clinical factors for daptomycin failure: a retrospective cohort study utilizing the Cubicin Outcomes Registry and Experience.
    Sakoulas G, Brown J, Lamp KC, Friedrich LV, Lindfield KC.
    Clin Ther; 2009 Sep; 31(9):1936-45. PubMed ID: 19843483
    [Abstract] [Full Text] [Related]

  • 9. Daptomycin in the treatment of bacteremia.
    Sakoulas G, Golan Y, Lamp KC, Friedrich LV, Russo R.
    Am J Med; 2007 Oct; 120(10 Suppl 1):S21-7. PubMed ID: 17904947
    [Abstract] [Full Text] [Related]

  • 10. Daptomycin for the treatment of enterococcal bacteraemia: results from the Cubicin Outcomes Registry and Experience (CORE).
    Mohr JF, Friedrich LV, Yankelev S, Lamp KC.
    Int J Antimicrob Agents; 2009 Jun; 33(6):543-8. PubMed ID: 19201165
    [Abstract] [Full Text] [Related]

  • 11. E. faecalis vancomycin-sensitive enterococcal bacteremia unresponsive to a vancomycin tolerant strain successfully treated with high-dose daptomycin.
    Cunha BA, Mickail N, Eisenstein L.
    Heart Lung; 2007 Jun; 36(6):456-61. PubMed ID: 18005808
    [Abstract] [Full Text] [Related]

  • 12. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus.
    Fowler VG, Boucher HW, Corey GR, Abrutyn E, Karchmer AW, Rupp ME, Levine DP, Chambers HF, Tally FP, Vigliani GA, Cabell CH, Link AS, DeMeyer I, Filler SG, Zervos M, Cook P, Parsonnet J, Bernstein JM, Price CS, Forrest GN, Fätkenheuer G, Gareca M, Rehm SJ, Brodt HR, Tice A, Cosgrove SE, S. aureus Endocarditis and Bacteremia Study Group.
    N Engl J Med; 2006 Aug 17; 355(7):653-65. PubMed ID: 16914701
    [Abstract] [Full Text] [Related]

  • 13. Vancomycin-resistant enterococci bacteremia: risk factors for mortality and influence of antimicrobial therapy on clinical outcome.
    Han SH, Chin BS, Lee HS, Jeong SJ, Choi HK, Kim CO, Yong D, Choi JY, Song YG, Lee K, Kim JM.
    J Infect; 2009 Mar 17; 58(3):182-90. PubMed ID: 19233476
    [Abstract] [Full Text] [Related]

  • 14. Comparison of outcomes from daptomycin or linezolid treatment for vancomycin-resistant enterococcal bloodstream infection: A retrospective, multicenter, cohort study.
    Crank CW, Scheetz MH, Brielmaier B, Rose WE, Patel GP, Ritchie DJ, Segreti J.
    Clin Ther; 2010 Sep 17; 32(10):1713-9. PubMed ID: 21194593
    [Abstract] [Full Text] [Related]

  • 15. Incidence and outcome of vancomycin-resistant enterococcal bacteremia following autologous peripheral blood stem cell transplantation.
    Kapur D, Dorsky D, Feingold JM, Bona RD, Edwards RL, Aslanzadeh J, Tutschka PJ, Bilgrami S.
    Bone Marrow Transplant; 2000 Jan 17; 25(2):147-52. PubMed ID: 10673672
    [Abstract] [Full Text] [Related]

  • 16. Emergence of vancomycin-resistant Enterococcus bloodstream infections in southern Taiwan.
    Chou CH, Lee NY, Lee HC, Chang CM, Lee CC, Ko WC.
    J Microbiol Immunol Infect; 2012 Jun 17; 45(3):221-7. PubMed ID: 22578639
    [Abstract] [Full Text] [Related]

  • 17. Impact of the more-potent antibiotics quinupristin-dalfopristin and linezolid on outcome measure of patients with vancomycin-resistant Enterococcus bacteremia.
    Erlandson KM, Sun J, Iwen PC, Rupp ME.
    Clin Infect Dis; 2008 Jan 01; 46(1):30-6. PubMed ID: 18171210
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of daptomycin in patients with renal impairment: a multicenter retrospective analysis.
    Kullar R, McClellan I, Geriak M, Sakoulas G.
    Pharmacotherapy; 2014 Jun 01; 34(6):582-9. PubMed ID: 24658897
    [Abstract] [Full Text] [Related]

  • 19. Safety of high-dose intravenous daptomycin treatment: three-year cumulative experience in a clinical program.
    Figueroa DA, Mangini E, Amodio-Groton M, Vardianos B, Melchert A, Fana C, Wehbeh W, Urban CM, Segal-Maurer S.
    Clin Infect Dis; 2009 Jul 15; 49(2):177-80. PubMed ID: 19500039
    [Abstract] [Full Text] [Related]

  • 20. Bloodstream infections with vancomycin-resistant enterococci.
    Montecalvo MA, Shay DK, Patel P, Tacsa L, Maloney SA, Jarvis WR, Wormser GP.
    Arch Intern Med; 1996 Jul 08; 156(13):1458-62. PubMed ID: 8678715
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.